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Background. Non-invasive assessment of subclinical atherosclerosis by means of coronary
artery calcium scoring (CACS) and multi-slice computed tomography (MSCT) coronary
angiography could improve patients’ risk stratification. However, data relating observations on
CACS and MSCT coronary angiography to traditional risk assessment are scarce.
Methods and Results. In 314 consecutive outpatients (54 ± 13 years, 56% males) without
known CAD, CACS and 64-slice MSCT coronary angiography were performed. According to
the Framingham risk score (FRS), 51% of patients were at low, 24% at intermediate and 25%
at high risk, respectively. MSCT angiograms showing atherosclerosis were classified as showing
obstructive (‡50% luminal narrowing) CAD or not. Both CACS and MSCT coronary angi-
ography showed a high prevalence of normal coronary arteries in low FRS patients (70% and
61%, respectively). An increase in the prevalence of CACS >400 (4% low vs 19% intermediate
vs 36% high), CAD (39% low vs 79% intermediate vs 91% high), and obstructive CAD (15%
low vs 43% intermediate vs 58% high) was observed across the FRS categories (P < .0001 for
all comparisons).
Conclusions. A strong positive relationship exists between FRS and the prevalence and
extent of atherosclerosis. Especially in intermediate FRS patients, CACS and MSCT coronary
angiography provide useful information on the presence of subclinical atherosclerosis. (J Nucl
Cardiol 2009;16:368–75.)
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INTRODUCTION
Identification of patients at risk of developing cor-
onary artery disease (CAD) events is one of the most
challenging issues in clinical cardiology. For this pur-
pose, several scoring tools that take demographic and
clinical characteristics into account have been devel-
oped. These tools allow stratification of patients into
low-, intermediate-, and high-risk categories, in order to
determine the intensity of risk-modifying interven-
tions.1-3 Among them, the Framingham risk score (FRS)
is one of the most frequently used;1,4 it considers tra-
ditional risk factors (age, gender, diabetes mellitus,
systolic blood pressure, total cholesterol and HDL cho-
lesterol level, and smoking history) to predict the
10-year risk of hard CAD events. However, traditional
risk assessment may still fail to identify a considerable
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proportion of patients with future CAD events, since it
provides a statistical probability of having CAD rather
than a direct individual assessment.5 Indeed, it has been
observed that as much as 20% of CAD events can occur
in the absence of major cardiovascular risk factors.6
To improve risk stratification, direct visualization of
subclinical atherosclerosis has been advocated. Indeed,
previous studies have shown that non-invasive assess-
ment of the coronary artery calcium score (CACS), by
means of electron-beam computed tomography (EBCT)
or multi-slice computed tomography (MSCT) provides
prognostic information that is incremental to traditional
risk stratification.7 Recently, more detailed visualization
of the coronary arteries has become possible with the
introduction of MSCT coronary angiography.8-10 Possi-
bly, MSCT coronary angiography could also improve
patients’ risk stratification similar to CACS. However,
data relating observations on CACS and MSCT coronary
angiography to traditional risk assessment are scarce. Aim
of the present study therefore was to evaluate the preva-
lence of CAD across the FRS categories using CACS and
MSCT coronary angiography. In addition, differences in
CACS and MSCT coronary angiography findings




The study population consisted of 314 consecutive outpa-
tients clinically referred to MSCT for coronary evaluation, due
to an increased risk profile and/or stable chest pain complaints.
Patients with typical angina, known history of CAD and/or
contraindications to MSCT were not included in the study, as
well as patients who were not in sinus rhythm during the MSCT
examination. History of CAD was defined as the presence of
previous acute coronary syndrome, percutaneous or surgical
coronary revascularization, and/or one or more angiographi-
cally documented coronary artery stenosis C50% luminal
diameter.11 Contraindications for MSCT were: (1) known
allergy to iodinated contrast agent, (2) renal failure (defined as
glomerular filtration rate\30 mL/min), and (3) pregnancy.
For each patient, the presence of coronary risk factors
(diabetes mellitus, systemic hypertension, hypercholesterol-
emia, positive family history, cigarette smoking, and obesity)
and the presence of chest pain complaints (atypical angina and
non-cardiac chest pain), both defined in accordance to previ-
ously published guidelines,4,12-15 were recorded. The
Framingham 10-year risk of hard CAD events was also cal-
culated as previously described in the National Cholesterol
Education Program’s Adult Treatment Panel III report.4 In
accordance with the FRS, the study population was then cat-
egorized as at low (\10%), intermediate (10-20%), and high
risk ([20%).4 In addition, patients were further divided as
being asymptomatic or symptomatic.
MSCT Data Acquisition
MSCT coronary angiography was performed with a
64-slice MSCT scanner (Aquilion 64, Toshiba Medical Sys-
tems, Japan). The heart rate and blood pressure were monitored
before the examination in each patient. In the absence of
contraindications, patients with a heart rate C65 beats/minute
were administered oral ß-blockers (metoprolol, 50 or 100 mg,
single dose, 1 hour before the examination).
First, a prospective coronary calcium scan without con-
trast was performed, followed by 64-slice MSCT coronary
angiography, performed according to protocols previously
described.16 Data were subsequently transferred to dedicated
workstations for post-processing and evaluation (Advantage,
GE Healthcare, USA and Vitrea 2, Vital Images, USA).
MSCT Data Analysis
The MSCT data analysis was performed by two experi-
enced observers who had no knowledge of the patient’s
medical history and symptom status; disagreement was solved
by consensus or evaluation by a third observer.
Coronary artery calcium score. Coronary
artery calcium was identified as a dense area in the coronary
artery [130 Hounsfield units. A total CACS was recorded for
each patient. In accordance with the value of total CACS,
patients were subsequently categorized as having no calcium
(total score = 0) or low (total score = 1-100), moderate (total
score = 101-400), and severe (total score [ 400) CACS.17
MSCT coronary angiography. MSCT coronary
angiograms were evaluated for the presence of obstructive
CAD (C50% luminal narrowing) on a patient and vessel level.
For this purpose, both the original axial dataset as well as
curved multi-planar reconstructions were used. Each vessel was
evaluated for the presence of any atherosclerotic plaque,
defined as structures [1 mm2 within and/or adjacent to the
coronary artery lumen, which could be clearly distinguished
from the vessel lumen and the surrounding pericardial tissue, as
described previously.9 Subsequently, the vessels were further
classified as 1. completely normal, 2. having non-obstructive
CAD when atherosclerotic lesions \50% of luminal diameter
were present, or 3. having obstructive CAD when atheroscle-
rotic lesions C50% of luminal diameter were present.
The prevalence of CAD (including obstructive and non-
obstructive CAD), obstructive CAD, the presence of obstructive
CAD in one vessel (single-vessel disease) or two or three ves-
sels (multi-vessel disease), and location in the left main (LM)
and/or proximal left anterior descending (LAD) coronary artery
were evaluated. Multi-vessel disease and LM and/or proximal
LAD disease were considered to represent high-risk features.
Statistical Analysis
Continuous variables are expressed as mean (standard
deviation) or as median (25th to 75th percentile range), when
not normally distributed. Categorical variables are expressed
as absolute numbers (percentages). The differences in contin-
uous variables were assessed using the Student t test when
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normally distributed and the Mann-Whitney test when not
normally distributed. V2 for greater than two-by-two and
Fisher exact for two-by-two contingency tables were computed
to test for differences in categorical variables. A P value\.05
was considered statistically significant. Statistical analyses




Baseline characteristics of the study population are
shown in Table 1. The mean age was 54 ± 13 years, and
177 (56%) patients were male. A total of 152 (48%)
patients were asymptomatic, while 82 (26%) patients
had history of atypical angina and 80 (26%) patients had
a history of non-cardiac chest pain. The FRS was low,
intermediate, and high, respectively, in 159 (51%), 77
(24%), and 78 (25%) patients.
MSCT Calcium Scoring and Coronary
Angiography
Table 2 and Figures 1 and 2 depict the results of
calcium scoring and MSCT coronary angiography in the
overall population and among asymptomatic and
symptomatic patients.
Table 1. Baseline characteristics of the study
population (n = 314)
Age (years) 54 ± 13
Gender (male/female) 177/137
Diabetes mellitus 69 (22%)
Hypertension 148 (47%)
Systolic blood pressure 134 ± 19
Diastolic blood pressure 81 ± 11
Hypercholesterolemia 105 (33%)
Total cholesterol (mmol/L) 5.2 ± 1.2
HDL-cholesterol (mmol/L) 1.5 ± 0.4
Family history of coronary artery disease 123 (39%)
Smoking history 88 (28%)
Overweight 125 (40%)
Obesity 58 (18%)
Body mass index (kg/m2) 27 ± 5









Data are expressed as means ± SD and n (%).













1 (0–159) 0 (0–156) 2 (0–214) ns
Zero 157 (50%) 78 (51%) 79 (49%) ns
Low 63 (20%) 31 (21%) 32 (20%) ns
Moderate 44 (14%) 20 (13%) 24 (15%) ns




120 (38%) 59 (39%) 61 (38%) ns
Non-obstructive
CAD
92 (29%) 46 (30%) 46 (28%) ns
Obstructive CAD 102 (33%) 47 (31%) 55 (34%) ns
Data are expressed as median (25th to 75th percentile range), and n (%).
CAD, Coronary artery disease.
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Coronary artery calcium score. As shown in
Table 2, the median CACS was 1 (25th to 75th per-
centile range 0-159). No calcium was observed in 157
(50%), while CACS was low in 63 (20%) patients,
moderate in 44 (14%), and severe in 50 (16%) patients.
The median CACS did not differ between asymp-
tomatic and symptomatic patients and the prevalence of
no calcium and minimal, mild, moderate, and severe
coronary calcifications was not statistically different
between the two groups (Table 2).
Relationship between CACS and FRS As shown in
Figure 1A, calcium was absent in 112 (70%) patients
with low FRS, 26 (34%) patients with intermediate FRS,
and in 19 (24%) patients with high FRS. Overall, a
decrease in the prevalence of CACS zero and an
increase in the prevalence of severe CACS were
observed in line with increasing FRS (Figure 1A).
However, among all three FRS categories still a signif-
icant proportion of patients presented with low and
moderate CACS.
As shown in Figure 1B and C, this positive rela-
tionship between FRS and CACS was similarly present
among both asymptomatic and symptomatic patients.
MSCT coronary angiography. As shown in
Table 2, 120 (38%) patients were classified as having
no CAD based on MSCT. A total of 92 (29%) patients
showed non-obstructive CAD, whereas at least one
significant (C50% luminal narrowing) stenosis was
observed in the remaining 102 (33%) patients.
Obstructive single-vessel disease was present in 54
(17%) patients, whereas multi-vessel disease was noted
in 48 (15%) patients. Obstructive CAD in the LM and/or
proximal LAD was present in 37 (12%) patients, of
which 24 also showed multi-vessel disease. Accord-
ingly, 61 (19%) patients were identified as having high-
risk features.
No difference in the prevalence of no CAD, and
non-obstructive and obstructive CAD was observed
between asymptomatic and symptomatic patients
(Table 2).
Relationship between MSCT coronary angiography
results and FRS As shown in Figure 2A, normal coro-
nary arteries were observed in 97 (61%) patients with
low FRS, 16 (21%) patients with intermediate FRS, and
7 (9%) patient with high FRS. Overall, a decrease in the
prevalence of normal coronary arteries and an increase
Figure 1. Relationship between CACS and Framingham 10-year risk of hard coronary heart
disease events in the overall population (A), among asymptomatic patients (B), and among
symptomatic patients (C). The proportion of patients with no calcium, low CACS, intermediate
CACS, and severe CACS differed significantly across the three FRS categories. CACS, Coronary
artery calcium score; FRS, Framingham risk score.
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in the prevalence of obstructive CAD were observed in
line with increasing FRS (Figure 2A). Moreover, an
increase in the prevalence of high-risk features was
observed across the FRS categories (13 (8%) patients in
the low FRS versus 21 (27%) in the intermediate FRS
versus 27 (35%) in the high FRS; P \ .0001). Never-
theless, a significant proportion of patients with non-
obstructive CAD was present in each category.
As shown in Figure 2B and C, this positive rela-
tionship between FRS and CAD was similarly present
among both asymptomatic and symptomatic patients.
DISCUSSION
The present study describes the prevalence and
extent of CAD, assessed by means of both CACS and
MSCT coronary angiography, across the FRS categories
in a large cohort of patients. Both CACS and MSCT
coronary angiography showed a high prevalence of
normal coronary arteries in low FRS patients (70% and
61%, respectively), which decreased in patients with
intermediate and high FRS. Similarly, an increase in the
prevalence of high CACS and obstructive or even high-
risk CAD were observed with increasing FRS. However,
moderate calcium on CACS as well as non-obstructive
CAD on MSCT coronary angiography were identified
across all FRS categories.
In line with the current observations, an overall
increase in the prevalence and extent of atherosclerosis
in relation to FRS has been reported in several previous
studies.18-21 At the same time, these studies have also
highlighted a discrepancy between the presence of tra-
ditional risk factors and the presence of subclinical
atherosclerosis: substantial atherosclerosis was fre-
quently observed in patients at low to intermediate risk,
while being absent in patients deemed at high risk. Also
in the current study, atherosclerosis was identified across
all FRS categories. These observations have led to the
notion that (selective) atherosclerosis imaging may
provide valuable information in addition to traditional
risk assessment. Indeed, several large clinical trials have
demonstrated that CACS has incremental value over risk
factors.7,22,23 In a large cohort of 1461 asymptomatic
individuals, Greenland et al7 demonstrated that knowl-
edge of a high CACS resulted in superior risk
stratification as compared to FRS alone. Other investi-
gations have reported similar observations.22,23
Accordingly, addition of an atherosclerosis marker such
Figure 2. Relationship between MSCT coronary angiography and Framingham 10-year risk of
hard coronary heart disease events in the overall population (A), among asymptomatic patients (B),
and among symptomatic patients (C). The proportion of patients with normal coronary arteries,
non-obstructive CAD, and obstructive CAD differed significantly across the three FRS categories.
CAD, Coronary artery disease; FRS, Framingham risk score.
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as CACS can significantly modify initially predicted risk
and can alter clinical decision-making and subsequent
therapy/patients management. Knowledge of subclinical
atherosclerosis may be of particular value in patients at
intermediate risk. In these patients, who represent a
substantial part of the population, clinical management
is frequently uncertain. In the present study, evaluation
by means of MSCT showed that coronary calcium was
absent in 34% of patients. In contrast, a CACS
exceeding 100 was observed in 45% of patients. Simi-
larly, MSCT coronary angiography showed normal
coronary arteries in 21%, whereas obstructive disease
was noted in 43% of patients. Moreover, high-risk
features were identified in 27%. Accordingly, these
observations indicate that underlying atherosclerosis can
be identified (but also ruled out) in a substantial pro-
portion of patients at intermediate FRS. Possibly,
refinement of risk using atherosclerosis imaging may
allow more appropriate targeting of preventive measures
in these patients. Indeed, the current American College
of Cardiology appropriateness criteria for cardiac com-
puted tomography suggest that assessment of calcium
may be a ‘‘reasonable approach’’ among intermediate
FRS patients, although substantial uncertainty remains
regarding its general applicability.24
In low risk patients, the use of imaging remains
controversial. In general, the prevalence of abnormal
coronary arteries will be low. Indeed, in the present
study, the prevalence of normal coronary arteries was
high both on CACS and MSCT coronary angiography.
Also, prognostic studies addressing CACS in relation to
FRS observed that CACS had no additive value in
patients with a FRS \10%.7 Still, recent data suggest
that perhaps in certain subsets of individuals deemed at
low risk by FRS, such as women younger than 70 years
old, CACS may identify higher risk in a considerable
proportion.25,26 Nevertheless, more data are needed
before evaluation of atherosclerosis can be recom-
mended in patients with low FRS.
In patients with high FRS on the other hand, the
incremental value of atherosclerosis imaging remains
debatable as well. In line with previous investigations,
we observed a high prevalence of coronary calcium
(76%). Moreover, the prevalence of abnormal coronary
arteries on MSCT coronary angiography was even
higher, 91%. Finally, a high prevalence of high-risk
features was noted on MSCT coronary angiography as
well (35%). Indeed, in this group of patients, the pres-
ence of high risk has already been established and these
patients should receive targeted anti-atherosclerotic
measures regardless of imaging results. In this context,
assessment with MSCT coronary angiography may be
favored over CACS as the former may provide a supe-
rior estimate of total plaque burden. Moreover, another
advantage of MSCT coronary angiography could be the
fact that it allows identification of high-risk features
such as left main or multi-vessel disease. Possibly, these
patients may benefit from even more aggressive mea-
sures, including revascularization, although supporting
data in asymptomatic patients are scarce.
It is important to realize that thus far, the majority
of data relating coronary atherosclerosis to FRS have
been obtained using CACS with EBCT and data relating
MSCT coronary angiography to clinical characteristics
are scarce. Moreover, MSCT coronary angiography has
mainly been applied in high-risk symptomatic patients
in order to determine its value in the diagnosis of CAD
rather than in risk assessment. As a result, only few data
are available concerning its prognostic value.27,28 Pre-
liminary studies however suggest that MSCT coronary
angiography may provide prognostic information
incremental to baseline risk stratification,29 although no
systematic comparisons to FRS are currently available.
In addition, no studies are available that evaluate the
relative merits of CACS and MSCT coronary angiog-
raphy with regard to risk stratification. Importantly,
efficacy in improving patient outcome remains to be
confirmed for both techniques.
The present study has some limitations that should
be acknowledged. First, it is a single center experience
with a relatively low sample size as compared to pre-
vious studies relating CACS to FRS. However, it is also
one of the first relating both CACS and MSCT coronary
angiography to FRS in patients without symptoms typ-
ical for CAD. Unfortunately, no follow-up data were
available. Future studies should address whether MSCT
coronary angiography may allow re-stratification of risk
similar or even superior to CACS. Second, the FRS was
developed in, and should be applied to, asymptomatic
individuals only; however, due to the radiation exposure
associated with MSCT coronary angiography, and the
lack of evidence in this setting, use in truly asymptom-
atic patients cannot be recommended at present. This
limitation could be overcome by more extensive
implementation of dose-saving algorithms, which are
likely to result in substantial dose reduction to\3 mSv,
without degradation of image quality.30,31
CONCLUSION
A strong positive relationship exists between FRS
and the prevalence and extent atherosclerosis on CACS
and MSCT coronary angiography. Both techniques
showed a high prevalence of normal coronary arteries in
low FRS patients versus a low prevalence in high FRS
patients. In intermediate FRS patients, however, CACS
and MSCT coronary angiography may provide useful
information on the presence of subclinical atherosclerosis.
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